First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma
First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma
Case Western Reserve University School of Medicine, Cleveland, OH
MYCN-amplified neuroblastoma are addicted to iron and vulnerable to system Xc- inhibition
MYCN-amplified neuroblastoma are addicted to iron and vulnerable to system Xc- inhibition
Virginia Commonwealth University, Richmond, VA
The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model
The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model
Albert Einstein College of Medicine, New York, NY
Exploiting NAD Metabolism Defects in Pediatric Brain Tumors
Exploiting NAD Metabolism Defects in Pediatric Brain Tumors
Yale University, New Haven, CT
Stimulating Macrophages to Eat Pediatric Brain Cancer: Combining Anti-CD47 and Irradiation to Enhance the Treatment of Group 3 Medulloblastoma
Stimulating Macrophages to Eat Pediatric Brain Cancer: Combining Anti-CD47 and Irradiation to Enhance the Treatment of Group 3 Medulloblastoma
University of Utah, Salt Lake City, UT
Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma
Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma
Beckman Research Institute of the City of Hope, Duarte, CA
Boosting Immunovirotherapy with Tumor Vaccination to Treat Pediatric Malignant Brain Tumors
Boosting Immunovirotherapy with Tumor Vaccination to Treat Pediatric Malignant Brain Tumors
University of Alabama at Birmingham, Birmingham, AL
Understanding the role of SMARCD1(BAF60A) in malignant rhabdoid
Understanding the role of SMARCD1(BAF60A) in malignant rhabdoid
Trustees of Dartmouth College, Lebanon, NH
Development of anti-KIT antibodies and immunotoxins as therapeutics and HSCT conditioning agents for pediatric acute myeloid leukemia
Development of anti-KIT antibodies and immunotoxins as therapeutics and HSCT conditioning agents for pediatric acute myeloid leukemia
Stanford University, Stanford, CA
Polycomb inhibition sensitizes AML to anthracycline therapy
Polycomb inhibition sensitizes AML to anthracycline therapy
The Research Institute at Nationwide Children’s Hospital, Columbus, OH
Arginine methylation as a potential therapeutic target in high-risk neuroblastoma
Arginine methylation as a potential therapeutic target in high-risk neuroblastoma
University of Rochester, Rochester, NY
Pediatric Cancer Data Commons
Pediatric Cancer Data Commons
University of Chicago, Chicago, Illinois
Artificial Intelligence for Pediatric Cancer
Artificial Intelligence for Pediatric Cancer
Stanford University, Palo Alto, CA
Clinical Trial Decision Aid (DECIDES) for Adolescents and Young Adults with Cancer and their Caregivers
Clinical Trial Decision Aid (DECIDES) for Adolescents and Young Adults with Cancer and their Caregivers
Children’s Hospital of Philadelphia, Philadelphia, PA
Activation of NF-kB in Neuroblastoma Myeloid Cells
Activation of NF-kB in Neuroblastoma Myeloid Cells
Johns Hopkins University School of Medicine, Baltimore, MD
Uncovering the Contribution of RNA Binding Proteins to Neuroblastoma Aggression
Uncovering the Contribution of RNA Binding Proteins to Neuroblastoma Aggression
Emory University – Winship Cancer Institute, Atlanta, GA
A Novel Approach to Target ACVR1 as a Treatment to Pediatric Cancer
A Novel Approach to Target ACVR1 as a Treatment to Pediatric Cancer
Georgia Tech Research Corporation, Atlanta, GA
Overcoming Innate Immune Evasion in Pediatric High Grade Glioma
Overcoming Innate Immune Evasion in Pediatric High Grade Glioma
University of Colorado Denver, AMC and DC, Aurora, CO
L3MBTL3, A Therapeutic Target in Acute Myeloid Leukemia
L3MBTL3, A Therapeutic Target in Acute Myeloid Leukemia
The Regents of the University of Michigan, Ann Arbor, MI
Targeting RNA Processing Defects of Ewing Sarcoma
Targeting RNA Processing Defects of Ewing Sarcoma
UT Health Science Center at San Antonio, San Antonio, TX